Methylphenidate-induced autoimmune hepatitis.
Lewis
Jason J
JJ
Department of Internal Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA. jjl8v@virginia.edu
Iezzoni
Julia C
JC
Berg
Carl L
CL
D000410:Alanine Transaminase / Q000097:blood; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D003863:Depression / Q000188:drug therapy; D019693:Hepatitis, Autoimmune / Q000097:blood / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects*; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D011239:Prednisolone; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin